UBS Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7M | Buy |
3,120,155
+2,749,416
| +742% | +$14M | ﹤0.01% | 2925 |
|
|
2025
Q4 | $1.58M | Buy |
370,739
+340,571
| +1,129% | +$1.29M | ﹤0.01% | 5175 |
|
|
2025
Q3 | $96.2K | Sell |
30,168
-377,867
| -93% | -$851K | ﹤0.01% | 7144 |
|
|
2025
Q2 | $926K | Sell |
408,035
-338,753
| -45% | -$546K | ﹤0.01% | 5510 |
|
|
2025
Q1 | $475K | Buy |
746,788
+238,232
| +47% | +$185K | ﹤0.01% | 5890 |
|
|
2024
Q4 | $524K | Buy |
508,556
+439,421
| +636% | +$473K | ﹤0.01% | 5807 |
|
|
2024
Q3 | $81.6K | Sell |
69,135
-1,233
| -2% | -$1.57K | ﹤0.01% | 6491 |
|
|
2024
Q2 | $85.8K | Buy |
70,368
+49,875
| +243% | +$99.3K | ﹤0.01% | 6296 |
|
|
2024
Q1 | $44.7K | Buy |
20,493
+446
| +2% | +$823 | ﹤0.01% | 6561 |
|
|
2023
Q4 | $31.1K | Buy |
20,047
+1,344
| +7% | +$1.77K | ﹤0.01% | 6826 |
|
|
2023
Q3 | $24.1K | Sell |
18,703
-2,737
| -13% | -$4.31K | ﹤0.01% | 6700 |
|
|
2023
Q2 | $36.9K | Sell |
21,440
-5,353
| -20% | -$8.89K | ﹤0.01% | 6627 |
|
|
2023
Q1 | $40.5K | Sell |
26,793
-19,007
| -42% | -$43K | ﹤0.01% | 6598 |
|
|
2022
Q4 | $73.3K | Buy |
45,800
+28,007
| +157% | +$41.4K | ﹤0.01% | 6394 |
|
|
2022
Q3 | $26K | Buy |
17,793
+13,585
| +323% | +$20.9K | ﹤0.01% | 7038 |
|
|
2022
Q2 | $8K | Buy |
4,208
+2,500
| +146% | +$4.79K | ﹤0.01% | 8296 |
|
|
2022
Q1 | $5K | Sell |
1,708
-138,773
| -99% | -$533K | ﹤0.01% | 9106 |
|
|
2021
Q4 | $608K | Sell |
140,481
-16,692
| -11% | -$97.8K | ﹤0.01% | 4821 |
|
|
2021
Q3 | $800K | Buy |
157,173
+131,922
| +522% | +$706K | ﹤0.01% | 4372 |
|
|
2021
Q2 | $160K | Sell |
25,251
-56,209
| -69% | -$438K | ﹤0.01% | 5519 |
|
|
2021
Q1 | $630K | Buy |
81,460
+80,052
| +5,686% | +$634K | ﹤0.01% | 4692 |
|
|
2020
Q4 | $9K | Buy |
1,408
+208
| +17% | +$1.49K | ﹤0.01% | 7553 |
|
|
2020
Q3 | $8K | Hold |
1,200
| – | – | ﹤0.01% | 7003 |
|
|
2020
Q2 | $10K | Sell |
1,200
-21,457
| -95% | -$199K | ﹤0.01% | 7005 |
|
|
2020
Q1 | $174K | Sell |
22,657
-34,542
| -60% | -$241K | ﹤0.01% | 4825 |
|
|
2019
Q4 | $475K | Sell |
57,199
-32,032
| -36% | -$216K | ﹤0.01% | 4882 |
|
|
2019
Q3 | $658K | Buy |
89,231
+65,403
| +274% | +$645K | ﹤0.01% | 4322 |
|
|
2019
Q2 | $267K | Buy |
23,828
+11,790
| +98% | +$124K | ﹤0.01% | 4725 |
|
|
2019
Q1 | $130K | Sell |
12,038
-75,073
| -86% | -$1.11M | ﹤0.01% | 4888 |
|
|
2018
Q4 | $1.31M | Buy |
87,111
+75,258
| +635% | +$1.12M | ﹤0.01% | 3431 |
|
|
2018
Q3 | $219K | Buy |
11,853
+9,544
| +413% | +$217K | ﹤0.01% | 4993 |
|
|
2018
Q2 | $53K | Sell |
2,309
-43,628
| -95% | -$1.11M | ﹤0.01% | 5920 |
|
|
2018
Q1 | $1.31M | Buy |
45,937
+34,767
| +311% | +$992K | ﹤0.01% | 3498 |
|
|
2017
Q4 | $236K | Sell |
11,170
-4,149
| -27% | -$86K | ﹤0.01% | 4799 |
|
|
2017
Q3 | $278K | Buy |
15,319
+12,800
| +508% | +$200K | ﹤0.01% | 4633 |
|
|
2017
Q2 | $39K | Sell |
2,519
-525
| -17% | -$7.91K | ﹤0.01% | 5831 |
|
|
2017
Q1 | $53K | Sell |
3,044
-1,018
| -25% | -$13.4K | ﹤0.01% | 5477 |
|
|
2016
Q4 | $45K | Buy |
4,062
+3,186
| +364% | +$38.6K | ﹤0.01% | 5902 |
|
|
2016
Q3 | $14K | Buy |
+876
| New | +$10.6K | ﹤0.01% | 6551 |
|
|
2016
Q2 | – | Sell |
-402
| Closed | -$5K | – | 7754 |
|
|
2016
Q1 | $5K | Sell |
402
-262
| -39% | -$3.64K | ﹤0.01% | 6996 |
|
|
2015
Q4 | $14K | Buy |
+664
| New | +$10.5K | ﹤0.01% | 7050 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
